Aims
Epidemiological
studies report the beneficial effects of habitual coffee consumption on
incident arrhythmia, cardiovascular disease (CVD), and mortality.
However, the impact of different coffee preparations on cardiovascular
outcomes and survival is largely unknown. The aim of this study was to
evaluate associations between coffee subtypes on incident outcomes,
utilizing the UK Biobank.
Methods and results
Coffee
subtypes were defined as decaffeinated, ground, and instant, then
divided into 0, <1, 1, 2–3, 4–5, and >5 cups/day, and compared
with non-drinkers. Cardiovascular disease included coronary heart
disease, cardiac failure, and ischaemic stroke. Cox regression modelling
with hazard ratios (HRs) assessed associations with incident
arrhythmia, CVD, and mortality. Outcomes were determined through ICD
codes and death records. A total of 449 563 participants (median 58
years, 55.3% females) were followed over 12.5 ± 0.7 years. Ground and
instant coffee consumption was associated with a significant reduction
in arrhythmia at 1–5 cups/day but not for decaffeinated coffee. The
lowest risk was 4–5 cups/day for ground coffee [HR 0.83, confidence
interval (CI) 0.76–0.91, P < 0.0001] and 2–3 cups/day for instant coffee (HR 0.88, CI 0.85–0.92, P < 0.0001).
All coffee subtypes were associated with a reduction in incident CVD
(the lowest risk was 2–3 cups/day for decaffeinated, P = 0.0093; ground, P < 0.0001; and instant coffee, P < 0.0001)
vs. non-drinkers. All-cause mortality was significantly reduced for all
coffee subtypes, with the greatest risk reduction seen with
2–3 cups/day for decaffeinated (HR 0.86, CI 0.81–0.91, P < 0.0001); ground (HR 0.73, CI 0.69–0.78, P < 0.0001); and instant coffee (HR 0.89, CI 0.86–0.93, P < 0.0001).
Conclusion
Decaffeinated,
ground, and instant coffee, particularly at 2–3 cups/day, were
associated with significant reductions in incident CVD and mortality.
Ground and instant but not decaffeinated coffee was associated with
reduced arrhythmia.
No comments:
Post a Comment